Neurotrophin-4 mediated TrkB activation reinforces morphine-induced analgesia (original) (raw)

References

  1. Law, P.Y., Wong, Y.H. & Loh, H.H. Annu. Rev. Pharmacol. Toxicol. 40, 389–430 (2000).
    Article CAS Google Scholar
  2. Luttrell, L.M., Daaka, Y. & Lefkowitz, R.J. Curr. Opin. Cell Biol. 11, 177–183 (1999).
    Article CAS Google Scholar
  3. Lee, F.S. & Chao, M.V. Proc. Natl. Acad. Sci. USA 98, 3555–3560 (2001).
    Article CAS Google Scholar
  4. McLaughlin, J.P. & Chavkin, C. Mol. Pharmacol. 59, 1360–1368 (2001).
    Article CAS Google Scholar
  5. Appleyard, S.M., McLaughlin, J.P. & Chavkin, C. J. Biol. Chem. 275, 38281–38285 (2000).
    Article CAS Google Scholar
  6. Yan, Q. et al. J. Comp. Neurol. 378, 135–157 (1997).
    Article CAS Google Scholar
  7. Ding, Y.Q., Kaneko, T., Nomura, S. & Mizuno, N. J. Comp. Neurol. 367, 375–402 (1996).
    Article CAS Google Scholar
  8. Middlemas, D.S., Meisenhelder, J. & Hunter, T. J. Biol. Chem. 269, 5458–5466 (1994).
    CAS PubMed Google Scholar
  9. Guiton, M., Gunn-Moore, F.J. & Tavare, J.M. Biochem. Soc. Trans. 23, 176S (1995).
    Article CAS Google Scholar
  10. Segal, R.A. et al. J. Biol. Chem. 271, 20175–20181 (1996).
    Article CAS Google Scholar
  11. Patapoutian, A. & Reichardt, L.F. Curr. Opin. Neurobiol. 11, 272–280 (2001).
    Article CAS Google Scholar
  12. Saarelainen, T. et al. Mol. Cell. Neurosci. 16, 87–96 (2000).
    Article CAS Google Scholar
  13. Minichiello, L. et al. Neuron 21, 335–345 (1998).
    Article CAS Google Scholar
  14. Siuciak, J.A., Altar, C.A., Wiegand, S.J. & Lindsay, R.M. Brain Res. 633, 326–330 (1994).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank D. Kaplan for TrkB antibody and M. Malcangio for advice on NT-4 release assay. Supported by Biotechnology Program of the EU QLG3-1999-00602, Swedish Medical Research Council, Swedish Cancer Society and Göran Gustafssons Foundation (P.E.); fellowship from David and Astrid Hageléns Foundation (G.L.); Academy of Finland, TEKES and Sigrid Juselius Foundation (E.C.).

Author information

Authors and Affiliations

  1. Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, S-17177, Sweden
    Guilherme Lucas, Tibor Harkany, Karin Agerman & Patrik Ernfors
  2. Department of Neuroscience, Karolinska Institutet, Stockholm, S-17177, Sweden
    Gustavo Paratcha, Carl Holmgren & Yuri Zilberter
  3. Department of Neurobiology, A.I. Virtanen Institute, University of Kuopio, Kuopio, 70211, Finland
    Panu Hendolin, Mikko Sairanen & Eero Castren
  4. European Molecular Biology Laboratory, via Ramarini 32, 00016 Monterotondo, Rome, Italy
    Liliana Minichiello

Authors

  1. Guilherme Lucas
    You can also search for this author inPubMed Google Scholar
  2. Panu Hendolin
    You can also search for this author inPubMed Google Scholar
  3. Tibor Harkany
    You can also search for this author inPubMed Google Scholar
  4. Karin Agerman
    You can also search for this author inPubMed Google Scholar
  5. Gustavo Paratcha
    You can also search for this author inPubMed Google Scholar
  6. Carl Holmgren
    You can also search for this author inPubMed Google Scholar
  7. Yuri Zilberter
    You can also search for this author inPubMed Google Scholar
  8. Mikko Sairanen
    You can also search for this author inPubMed Google Scholar
  9. Liliana Minichiello
    You can also search for this author inPubMed Google Scholar
  10. Eero Castren
    You can also search for this author inPubMed Google Scholar
  11. Patrik Ernfors
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toPatrik Ernfors.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1.

Morphine induced phosphoTrk immunoreactivity in brainstem nuclei. Confocal images of the trigeminal spinal nucleus and locus coeruleus (insets) neurons stained with anti-Trk autophosphorylation antibody 30 min after (a) morphine (10 mg/kg), (b) morphine (10 mg/kg) followed by naloxone (1 mg/kg), and (c) naloxone alone. Note increased immunoreactivity in morphine but not morphine plus naloxone or naloxone treated mice. Arrows indicate phospho-Trk positive cells in the spinal trigeminal nucleus. Scale bar, 200 μm for the trigeminal spinal nucleus and 75 μm for the locus coeruleus. Methods: C57/BL6 mice were treated with morphine (10 mg/kg, s.c.; n = 3), or with morphine (10 mg/kg, s.c.) followed by naloxone (1 mg/kg, i.p. n = 2) 10 min later, or only naloxone (1 mg/kg, i.p. n = 1). Thirty minutes after morphine treatment or 10 min after naloxone administration, mice were anesthetized by isoflurane (5% [v/v%] in 70% N2O and 30% O2) and transcardially perfused with ice-cold physiological saline (15 ml) that was followed by 80 ml of fixative composed of 4% paraformaldehyde, 0.1% glutaraldehyde and 1mM sodium orthovanadate in sodium phosphate buffer (PB, 0.1M, pH 7.4) at a flow rate of 4 - 4.5 ml/min. Whole brains were removed from the skulls and post-fixed in 4% paraformaldehyde and 1mM sodium orthovanadate in PB overnight. Brains were then cryoprotected in 30% sucrose in physiological saline for 24 hrs, cryostat sectioned at a 40-μm thickness, and collected in 0.1M PB with 0.1% Na-azide as preservative. Series of free-floating sections of all animals were processed simultaneously in a uniform manner. After extensive rinsing in PB, sections were pre-incubated in a mixture of 10% normal donkey serum (NDS, Jackson ImmunoResearch, USA), 5% normal bovine serum (BSA) and 0.1% triton X-100 in PB for 60 min. Subsequently, sections were exposed to the primary antibody rabbit anti-Tyr674,Tyr675-phosphorylated tyrosine kinase (1:25; Calbiochem, USA) in PB containing 1% NDS, 0.1% BSA and 0.1% triton X-100 for 48 hrs at 4 °C under continuous agitation of the incubation medium. Thereafter, sections were washed in repeated changes of PB and incubated with carbocyanine 3-conjugated donkey anti-rabbit secondary antibody (1:200; affinity-pure for multiple labeling without cross-reactivity with mouse serum proteins, Jackson) in PB containing 2% BSA for 2 hrs at room temperature. Next, sections were rinsed in PB, dipped in distilled water and mounted on fluorescence-free glasses. Sections were coverslipped using Entellan (in toluene). Sections were analyzed using confocal laser-scanning microscopy with appropriate excitation and emission filters (543 nm and 560-610 nm, respectively; Zeiss 510, Germany). Selected images were captured using identical pinhole, detector gain, detector offset, amplification gain and scanning control settings, where specimen of morphine-treated animals were used for calibration of scanning conditions. Subsequently, multi-panel plates of unmodified images were created employing Paint Shop Pro (v. 7.01, Jasc Inc., USA) and Adobe Photoshop (v. 6.0, Adobe Inc., USA). Scanning data: pinhole: 60 μm, (less than 1.9 micrometer optical slice), adjusted for even light distribution. Detector gain: 960; offset: -0.3; amplificator gain: 1; 100% laser excitation on 543 nm channel; speed: 7, lines: 4; zoom: (spinal trigeminal nucleus images): 1, Locus coeruleus images: 1.5. (JPG 48 kb)

Supplementary Fig. 2.

Measurements of morphine and morphine metabolites in the plasma of NT-4-/- and NT-4+/+ mice. Mice were decapitated 30 minutes after morphine administration (10 mg/kg, s.c.) and blood samples (300 μl) collected in ice-chilled tubes containing heparin (10 IU/ml) were centrifuged for separation of the plasma. Morphine (a), Morphine-6-glucuronide (b), and Morphine-3 glucuronide (c) were measured by a reverse phase HPLC column (C18, Spherisorb S3 ODS2 100 x 4 mm I.D.; 3 μm particles) and no difference was observed between wild-type (n = 5) and NT-4-/- (n = 6) mice (Student _t_-test). This shows that the difference in morphine response between mutated mice and wild-type mice is not caused by a difference in metabolisation of morphine. (JPG 34 kb)

Supplementary Table 1 (PDF 40 kb)

Supplementary Methods (PDF 14 kb)

Rights and permissions

About this article

Cite this article

Lucas, G., Hendolin, P., Harkany, T. et al. Neurotrophin-4 mediated TrkB activation reinforces morphine-induced analgesia.Nat Neurosci 6, 221–222 (2003). https://doi.org/10.1038/nn1021

Download citation